We assessed the ratio of RON, phosphorylated mTORC1, and phosphorylated rpS6 to the epithelial marker EpCAM and did not see a direct correlation between high levels of total RON protein and levels of activated mTORC1 or rpS6 in primary or metastatic disease. Here, MST1R is linked to metastatic neoplasm.